drug discovery

The COVID-19 pandemic has given businesses an unprecedented opportunity to implement technology-fueled changes to the way they…

Led by IvyCap Ventures, the pre-Series A funding round also saw participation from Hyperplane Venture Capital and a few angel…

INEOS donates £100 million to Oxford Univerity to set up the new institute to fight antimicrobial resistance

Sosei Heptares to get an upfront payment, research funding and potential near-term development milestones of up to £34 million…

The pharma sector is moving from being traditional to a highly technology-driven one, highlights Sanjeev Goel, Business Head,…

This collaboration aims to develop a disease-modifying treatment for synucleinopathies based on network kinetics of α-synuclein…

The closing of this transaction is subject to customary conditions and approvals, expected to complete before the end of 2020

NVIDIA will contribute its deep expertise in GPU optimisation and high-performance computational pipeline development, including…

The drug, which may improve life expectancy and quality for pancreatic cancer patients, was discovered after examining a hormone…

The CARE consortium comprises 37 teams from academic and non-profit research institutions and pharma companies